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It could not be shown that Q 1-AT-eontaining liposomal
therapy played a role in reducing damage to the heart valves of
these animals.
Although ampicillin-eontaining liposomes reduced vegeta-
tion size, this fInding cannot as yet be implemented in man.
Further studies are needed to determine the effect of liposomes
on ampicillin clearance, the places in which they concentrate,
and whether this therapy influences colony counts in cultures.
The authors thank the South Mrican Medical Research Council
for financial suppon.
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Platelet count and liver function tests in proteinuric
and chronic hypertension in pregnancy
J. VERHAEGHE, J. ANTHONY, D. A. DAVEY
Summary
Platelet counts and plasma enzyme estimations were per-
formed in 207 pregnant patients with proteinuric hypertension
and in 60 patients with chronic hypertension. Patients with
abruptio placentae were excluded. In the proteinuric hyper-
tensive patients a low platelet count « 150000/mm3) was
found in 63 (30%) and elevated transaminase levels in 50
(24%) and both abnormalities were present in 47 patients
(23%). The serum lactate dehydrogenase (LDH) value was
mildly elevated in most proteinuric hypertensive women, but
a markedly elevated LDH level ( > 400 IU/I) was usually
associated with other evidence of liver necrosis. Raised
plasma alkaline phosphatase and -y-glutamyhransferase levels
were not related to the occurrence or severity of liver necrosis.
In proteinuric hypertensive patients a low platelet count or
elevated transaminase level was associated with deteriorating
renal function, increased maternal morbidity, increased inci-
dence of low-birth-weight babies and a raised perinatal
mortality rate (149/1 000). In patients with chronic hyper-
tension, 1 had a low platelet count but none had elevated
transaminase, LDH or other enzyme levels and there was no
recorded perinatal mortality.
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Pre-eclampsia may affect both the haemostatic system and
liver function. Platelet activation and turnover are increased,
resulting in a reduced platelet count and this is associated with
disseminated intravascular coagulation (DIe) in many, but not
all, patients with proteinuric hypertension in pregnancy. I-3
Liver function, as measured by assays of plasma enzymes, may
also be impaired in patients with proteinuric hypertension.'
Two basic lesions have been described in post-monem liver
biopsies of eclamptic women: periportal haemorrhages and
ischaemic necrosis. 5 A low platelet count and abnormal liver
function tests often occur simultaneously··6 and, if both are
present, micro-angiopathic haemolytic anaemia is invariably
present. Weinstein7 used the acronym HELLP (Haemolysis,
Elevated Liver enzymes, and Low Platelets) for this entity,
and suggested that it should be regarded as a complication of
severe pre-eclampsia. The incidence in pre-eclampsia has been
reponed to be about 10%, and the occurrence of the HELLP
syndrome is associated with considerable maternal and perinatal
morbidity and monality.8.9
At GrOote Schuur Hospital Maternity Centre, Cape Tqwn,
we gained the impression that low platelet counts and raised
plasma enzyme levels were more common than had p~eviously
been described. Earlier studies of pre-eclamptic patients
included many cases of abruptio placentae, which may have
been responsible for the DIe and liver dysfunction, and
increased perinatal monality.
A study was designed to try to answer the following ques-
tions: (i) what is the incidence of a low platelet count and/or
abnormal plasma transaminase values in proteinuric hyper-
tensive patients presenting at this hospital? (ii) is a low platelet
count always accompanied by abnormal plasma transaminase
levels? (iil) which of the routinely performed plasma enzyme
assays provide the best indication of hepatic involvement? and
(iv) if patients with abruptio placentae are excluded, is ~e
fUlding of a low platelet count and/or abnormal transaminase




Groote Schuur Hospital Maternity Centre is the referral unit
for the Peninsula Maternal and Neonatal Services (PMNS)
and had a total of 26123 deliveries in 1988. This study was
started on 1 April 1989 and ended on 10 November 1989. The
hypertensive disorders of preFcy were classified according
to Davey and MacGillivray, 0 and patients with proteinuric
hypertension and chronic hypertension were recruited for the
study. 'Proteinuric hypertension' includes 'gestational' and
'unclassified' proteinuric hypertension and 'pre-eclampsia'
superimposed on known chronic hypertension. In the 'unclas-
sified' proteinuric hypertension group, all the patients became
non-proteinuric after delivery and, in retrospect, could be
classified as 'gestational'. Patients with the following conditions
were excluded: (I) abruptio placentae; (il) chronic renal disease,
including patients booking in early pregnancy with both hyper-
tension and proteinuria; (iil) known diabetes mellitus; (iv)
other medical disorders that might interfere with blood coagu-
lation or liver function (e.g. severe anaemia, leukaemia, liver
disorder); and (v) absence of blood samples taken in the 48
hours before or the 24 hours after delivery.
Platelet counts were measured by a Coulter Full Blood
Count Analyser. If the platelet count was found to be low
« l50000/mm\11 a Thrombo-C test was performed on a
Seguoia-Turner Whole Blood Platelet Analyser (Mountain
View, Calif, USA). The plasma liver enzyme and plasma
creatinine values in serum were measured by a SMAC n Auto
Analyser. If the serum aspartate aminotransferase (AST) and
alanine aminotransferase (ALT) values were above the normal
range on the SMAC Auto Analyser ( > 40 lUll and 53 lUll,
respectively), the plasma enzyme levels were measured with
kinetic assay kits (Boehring Diagnostics Inc., Somerville, NJ,
USA). The published normal ranges are AST - 7 - 25 lUll,
and ALT - 1 - 25 lUll, respectively; transaminase levels are
not altered by pregnancy.12 All samples with a raised 1'-
glutamyltransrerase (GGT) concentration on Auto-Analyser
(> 50 IU/l; normal < 40 lUll) were also confirmed by a
kinetic assay (Boehringer Mannheim GmbH, Germany). Only
when both AST and ALT were raised was the liver function con-
sidered to be abnormal. Plasma creatinine values were con-
sidered to be abnormal if> 82 }.Lmol/l (> 2 SD above the
mean for pregnancy).l3
The results of the liver function tests shown in the Tables
and Figures are the highest levels recorded in each patient.
The results of the laboratory tests in proteinuric hypertensive
patients with normal platelet counts and normal transaminase
levels, and in chronic hypertensive patients, were those per-
formed on samples taken closest to delivery (either in the 48-
hour period before or the 24-hour period after delivery).
The statistical significance of the differences in the numbers
of patients with abnormal tests in each group was analysed by
the x2 test or by the Fisher's exact test if the expected cell
frequency was < 5.
Results
We studied 207 consecutive patients who presented with
proteinuric hypertension and 60 consecutive patients who
presented with chronic hypertension in pregnancy.
Maternal characteristics and fetal outcome
Patients with proteinuric hypertension were younger. and of
lower parity than chronic hypertensive patients (Table I), 44%
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of the women with proteinuric hypertension being primigravid.
The mode of delivery, fetal birth weight, and maternal and
perinatal mortality in the two groups are shown in Table n.
TABLE I. AGE, RACE AND PARITY OF PATIENTS
Proteinuric Chronic
hypertension hypertension
No. % No. %
Age (yrs)
<20 42 20 1 2
20·34 148 72 38 63
~35 17 8 21 35
Race
Black 85 41 15 25
Cape Coloured 120 58 45 75
White 2 1
Parity
0 91 44 7 12
1 - 3 97 47 39 65
~4 19 9 14 23




No. % No. %
Delivery
Total 207 60
Spontaneous 56 27 33 55
Instrumental 18 9 4 7
CS 133 64 23 38
Birth weight (g)
<1000 28 13 0
1000-1999 81 38 4 7
2000-2999 78 37 27 44
~3 000 24 11· 30 49t
Maternal mortality 2 1 0
Perinatal mortality 22 11 0
Eclampsia 16 8 0
• 4 twin pregnancies.
t 1 twin pregnancy.
The seemingly high caesarean section (CS) rate of 64% in
the proteinuric hypertension group is because a large number
of the patients required delivery before 34 weeks' gestation for
either fetal distress and/or growth retardation or maternal
complications. Fifty-one per cent of the infants of the women
with proteinuric hypertension and only 7% of the infants of
chronic hypertensive mothers had birth weights of less than
2000 g. The perinatal mortality rate was 106/1000 in the
proteinuric hypertension group compared with 29,5/1000 for
the whole PMNS region. In the chronic hypertension group,
there was no recorded perinatal or maternal mortality. There
were 2 maternal deaths in the women with proteinuric hyper-
tension and the eclampsia rate was 8%.
Platelet count and plasma transaminases
Of the proteinuric hypertension patients 30% had a low
platelet count « l50ooo/mm3) and 24% had elevated plasma
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transaminase levels during pregnancy. Of patients with a low
platelet count, 75% also had elevated transaminase levels and
94% of patients with abnormal transaminase levels had a low
platelet count. Both a low platelet count and an abnormally
raised transaminase level were found in 23% of patients. There
was a wide variation in the degree of thrombocytopenia and
the levels of plasma transaminase. Of the patients w~th throm-
bocytopenia, 24% had a platelet count of < 50ooo/mm3 and
transaminase levels were often highly elevated (more than
lO-fold). .
Total bilirubin levels (normal range 1 - 17 1LmoVl) were
elevated in 52% of the women with abnormal transaminase
levels, but the increase was small in the majority of patients
(15 patients < 34 1LmoVl; 8 34-85 1Lmol/l). In 3 patients,
however, the bilirubin levels were increased more than 5-fold
(> 85 1Lmol/l) and all 3 had renal failure. The liver dysfunction
and the renal failure returned to normal after delivery in 2 of
these 3 women but the third patient died of combined hepatic
and renal failure.
Only 1 patient with chronic hypertension had a marginally
low platelet count and none of the patients with chronic
hypertension had abnormal serum transaminase or bilirubin
levels.
Plasma lactate dehydrogenase (LDH)
Most of the proteinuric hypertensive patients with abnormal
transaminase levels also had markedly elevated LDH levels
(> 400 lUll) (Fig. 1). Of the patients with proteinuric hyper-
tension but with normal platelet counts and transaminase
levels, 63% had raised LDH levels but the increase was small
- less than twice the normal range (200 - 399 lUll). Of
patients with chronic hypertension and normal platelet counts
and transaminase levels 24% had mildly raised plasma LDH.
Plasma alkaline phosphatase (AP)
AP levels were increased above the normal non-pregnant
range (30 - 115 lUll) in most patients owing to the normal
placental production of this enzyme, the increase occasionally
reaching concentrations more than 3 times the normal non-
pregnant mean. There was, however, no difference between
the AP levels of patients with proteinuric or chronic hyper-
tension (Fig. 2). Plasma AP concentrations did not correlate
with the level of transaminase in proteinuric hypertension and
patients with significantly raised bilirubin levels often had
normal AP concentrations.





2-3x T T +Normal
1-2x T -4- +Normal
Normal 1 8T T(~115U/Il
Fig. 2. Alkaline phosphatase levels in patients with proteinuric
and chronic hypertension. The length of the solid bars represents
the relative percentage of patients in each group wth an alkaline
phosphatase value in that particular range (group A ~ proteinuric
hypotension + abnormal transaminases; group B - proteinuric
hypertension + normal platelets and transaminases; group C =
chronic hypertension).
Fig. 1. LDH levels in patients with proteinuric and chronic hyper-
tension. The length of the solid bars represents the relative
percentage of patients in each group with an LDH value in that
particular range (group A - proteinuric hypotension + abnormal
transaminases; group B - proteinuric hypertension + normal
.platelets and transaminases; group C = chronic hypertension).
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GGT levels were raised in only 36% of proteinuric hyper-
tension patients with abnormal transaminase levels. Of 26
patients with both raised transaminase and bilirubin levels
only 8 had a raised GGT. Abnormally raised GGT levels were
found in a few isolated patients; this appeared unrelated to the
severity of the disease or other findings (Table Ill). The raised
GGT levels in these patients were probably due to alcohol
abuse and were associated with other indices of excessive
alcohol intake, e.g. a high mean corpuscular volume of erythro-
cytes.
Maternal and perinatal morbidity and
mortality
The maternal mortality, eclampsia rate, perinatal mortality
and incidence of infants with a birth weight of < 2 000 g and
serum creatinine levels in the proteinuric hypertensive patients
TABLE Ill. GGT LEVELS
























SAMJ VOL 79 18 MEI 1991 593






































< 2 000 g 44/67 66* * * 65/144 45 4/61 7
• P< 0,001 compared with groups with proteinuric hypertension and normal platelets, and chronic hypertension.
•• P < 0,002 compared with group with chronic hypertension.
••• P < 0,05 compared w~h group with proteinuric hypertension and normal platelets, and P < 0,001 compared w~h group with chronic hypertension.
I
with abnormal platelet counts and!or transaminase levels were
compared with those in proteinuric hypertensive patients with
normal platelet counts and normal transaminase levels (Table
IV). In the proteinuric hypertensive patients with abnormal
platelet counts and!or transaminase levels the perinatal mor-
tality rate was significantly increased at 149/1000 compared
with 83/1000 in the group with nortnal platelet counts and
transaminase levels. The incidence of low-birth-weight infants
of 66% was also higher in the former group compared with
45% in the latter group.
Of the proteinuric hypertensive patients with abnormal
platelet counts or transaminase levels 62% had a serum creati-
nine value of more than 82 JLmol/l and 6 patients had a value
of more than 250 JLmol/l. The 2 maternal deaths in this series
occurred in this latter group. There was no significant differ-
ence in the eclampsia rate in the proteinuric hypertensive
women with and without abnormal platelet counts or trans-
aminase levels.
Discussion
The incidence of low platelet counts (30%) and of elevated
plasma transaminase levels (24%) in women presenting with
proteinuric hypertension at Groote Schuur Hospital Maternity
Centre was much higher than the reported incidence of
10 - 12% of the so-called HELLP syndrome in other centres.9,14
The high incidence of low platelet counts in proteinuric
hypertensive women at Groote Schuur Hospital is, however,
comparable with the 29% in the series on eclamptic women
delivered at Parkland Memorial Hospital, Dallas, Texas, USA.2
A low platelet count and elevated plasma transaminase level
were very commonly associated. Patients with abnormal
transaminase levels almost always (94%) had a low platelet
count, but in 25% of patients with a low platelet count the
transaminase levels were within the normal range. A low
platelet count without a raised transaminase value may repre-
sent an earlier stage of a multisystem disorder.
The plasma enzyme measurements performed are relatively
nonspecific assays of intracellular enzymes that are normally
present in many tissues and are released into the circulation
after ceH necrosis or lysis, causing an increase in plasma
concentration. Elevated concentrations of plasma AST and
ALT levels are indicative of liver cell necrosis and sensitive
kinetic assays were therefore used to provide a more accurate
measure of these enzymes in all patients with raised plasma
transaminase levels on routine screening. Elevated transaminase
levels due to damage to the heart, kidney or muscles can, in
general, be excluded in this study, and raised levels of these
enzymes may therefore be regarded as providing a measure of
liver necrosis and liver cell damage. Of the two transaminases,
a high serum ALT concentration is more specific for liver cell
necrosis than a raised serum AST level, since the concentration
of ALT is relatively higher in the liver than in other tissues. In
women with normal serum ALT.concentrations, isolated mar-
ginally increased AST concentrations (between 1 and 1,5 times
the normal range) were sometimes observed, probably due to
haemolysis of the blood specimen because AST concentrations
are higher in red blood cells. 15
Of the other plasma enzymes routinely measured, LDH
may also be an indicator of liver involvement in proteinuric
hypertensive patients with normal transaminase levels. Mildly
raised LDH levels (less than twice the normal range) were
frequently found. This could have been due to haemolysis of
blood specimens, since LDH concentrations are also high in
erythrocytes. 15 When plasma transaminase levels were raised,
however, LDH levels were, on average, always very high -
with LDH concentrations of more than 400 U/l. Most of the
increase in LDH concentrations is reported to be due to an
increase in LDH iso-enzymes 1 and 2, which are mainly of
erythrocyte origin.6 Further studies of the LDH iso-enzyme
levels are necessary in both normal and proteinuric hyper-
tensive women in pregnancy to determine how much of the
raised LDH level is due to haemolysis of the blood specimens
and how much is due to liver necrosis.
Maternal morbidity is also increased in proteinuric hyper-
tensive patients with abnormal platelet counts or transaminase
levels and renal failure occurred in a number of these women,
even in the absence of abruptio placentae. The perinatal
mortality rate in the proteinuric hypertensive group with
abnormal platelet counts and transaminase levels was 5 times
higher than the average PMNS perinatal mortality and
approximately double that of proteinuric hypertensive women
with normal platelet counts and transaminase levels. The
incidence of low birth weight in infants was also higher in the
proteinuric hypertensive patients with abnormal compared
with normal platelet counts and transaminase levels. The high
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incidence of low-binh-weight infants was due to many of the
patients having to be delivered prematurely due to fetal com-
promise.
The cause of the increased platelet consumption and the
liver necrosis in proteinuric hypenensive mothers is not known,
but there is evidence that the coagulation cascade is activated
by injury to the endothelial cells of small vessels in pre-
eclampsia. 16 There is also considerable evidence of prostacyclin
deficiency in the uteroplacental unit and, to a lesser ettent, in
the general circulation in pre-eclampsia. 17 A low platelet count
is indicative of a moderate to severe DIe, which could well be
associated with fibrin deposition and thrombosis in liver sinu-
soids causing liver necrosis. Similar fibrin deposition could
occur in the renal anerioles causing decreased glomerular
function and possibly the occurrence of proteinuria. It is
possible that the deficiency in prostacyclin and the decrease in
the prostacyclin/thromboxane ratio may be more marked in
cenain organs, such as the utero-placental unit, kidney and
liver, possibly due to a factor inhibiting prostacyclin synthetase.
This would result in intravascular coagulation and fibrin
deposition within these organs, and consequent ischaemia and
cell damage and necrosis. Disseminated and local intravascular
coagulation is a serious complication of proteinuric hyper-
tension in pregnancy resulting in both maternal and perinatal
morbidity and monality.
The high incidence of low platelet counts and raised plasma
transaminase levels in women with proteinuric hypenension
and the serious prognostic implications make repeated
measurements of the platelet count and plasma enzyme levels
an essential part of the management of all such patients. These
tests are·often the only indication that a multisystem disorder
has developed and that the clinical condition of the mother is
serious and requires urgent treatment and delivery of the
fetus. Low-dose aspirin has recently been claimed to prevent
pre-eclampsia by vinue of its action in preferentially inhibiting
thromboxane synthetase in platelets compared with prostacylin
synthetase in the vascular endothelium so increasing the prosta-
cyclin/thromboxane ratio. 18 It would therefore be of consider-
able interest to see whether low-dose aspirin can prevent or
reduce the high incidence of thrombocytopenia and liver
necrosis in pre-eclampsia and whether it can reverse this
disorder once it has started.
In conclusion, proteinuric hypenension is frequently asso-
ciated with a low platelet count and raised plasma transaminase
levels, whereas, in contrast, chronic hypenension is rarely if
ever associated with these abnormalities. The development of
thrombocytopenia or impaired liver function is of major signifi-
cance in all patients with hypenensiOIi in pregnancy and is an
indication for routine platelet counts and liver enzyme esti-
mations - cenainly in all-patients with proteinuric hyper-
tension, since early recognition is essential to prevent maternal
and perinatal monality and morbidity.
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